VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Property, Plant & Equipment (Net) (2012 - 2026)

VivoSim Labs (VIVS) Property, Plant & Equipment (Net) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 VivoSim Labs 1.49 Mn 1.49 Mn - 189,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 189,000.00
Jun 30, 2026 189,000.00
Mar 31, 2026 206,000.00
Mar 31, 2026 206,000.00
Dec 31, 2025 248,000.00
Dec 31, 2025 248,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 359,000.00
Jun 30, 2025 359,000.00
Mar 31, 2025 419,000.00
Mar 31, 2025 419,000.00
Dec 31, 2024 479,000.00
Dec 31, 2024 479,000.00
Sep 30, 2024 545,000.00
Sep 30, 2024 545,000.00
Jun 30, 2024 601,000.00
Jun 30, 2024 601,000.00
Mar 31, 2024 669,000.00
Mar 31, 2024 669,000.00